These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 56818)

  • 1. [Treatment of hypotensive circular dysregulation using Gutron in practice].
    Kratz H
    Wien Med Wochenschr; 1975 Mar; 125(12):189-92. PubMed ID: 56818
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnosis and therapy of hypotensive circulatory disorders in general practice. Experiences with Gutron using the Thulesius-diagram for diagnosis and supervision of therapy].
    Sazovsky H; Pittner H
    Fortschr Med; 1979 Apr; 97(15):733-6. PubMed ID: 88400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of Gutron (Midodrin) in the treatment of arterial hypotension syndrome].
    Lukasik S; Markiewicz M; Petelenz T; Słopecka G; Axentii I; Kasprzak J; Mach A
    Pol Tyg Lek; 1984 Mar; 39(10):329-32. PubMed ID: 6206487
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy of midodrin in orthostatic circulatory disorders. Results of a 2d multicentric field study of 942 patients].
    Lossnitzer K; Letzel H
    Med Welt; 1983 Oct; 34(42):1190-3. PubMed ID: 6196595
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of hypotension in general practice with Gutron].
    Lacbnit VK
    Wien Med Wochenschr; 1975 Jun; 125(25-27):428-31. PubMed ID: 56819
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the effect of the alpha-receptor stimulant, gutron, in the orthostatic syndrome (author's transl)].
    Scholing WE
    Wien Klin Wochenschr; 1981 Jun; 93(13):429-34. PubMed ID: 6168121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midodrine. A new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome.
    Schirger A; Sheps SG; Thomas JE; Fealey RD
    Mayo Clin Proc; 1981 Jul; 56(7):429-33. PubMed ID: 6166817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gutron treatment of patients suffering from essential orthostatic hypotony. Part One--Hemodynamic non-invasive investigation.
    Axenti I; Petelenz T; Sosnoski M; Slomińska-Petelenz T
    Int Angiol; 1993 Jun; 12(2):132-7. PubMed ID: 7690384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tolerance tests of alpha-sympathomimetic agent, Gutron].
    Kiesewetter E; Deimer E; Fischer M; Höcker P; Mermon R; Mostbeck A; Pittner H; Witek F
    Wien Med Wochenschr Suppl; 1976 Dec; 37():3-8. PubMed ID: 64035
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine).
    Kaufmann H; Brannan T; Krakoff L; Yahr MD; Mandeli J
    Neurology; 1988 Jun; 38(6):951-6. PubMed ID: 2452997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midodrine. A review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders.
    McTavish D; Goa KL
    Drugs; 1989 Nov; 38(5):757-77. PubMed ID: 2480881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of midodrin in the treatment of the orthostatic syndrome (author's transl)].
    Hammerer I; Gassner I; Schwingshackl A
    Padiatr Padol; 1981; 16(1):59-68. PubMed ID: 6165954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midodrine prescribed to improve recurrent post-spaceflight orthostatic hypotension.
    Platts SH; Ziegler MG; Waters WW; Mitchell BM; Meck JV
    Aviat Space Environ Med; 2004 Jun; 75(6):554-6. PubMed ID: 15198285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midodrine for orthostatic hypotension.
    Med Lett Drugs Ther; 1997 Jun; 39(1003):59-60. PubMed ID: 9205432
    [No Abstract]   [Full Text] [Related]  

  • 15. Gutron treatment of patients suffering from essential orthostatic hypotony. Part Three--Hemodynamic-autonomic interactions.
    Petelenz T; Sosnowski M; Axenti I
    Int Angiol; 1993 Jun; 12(2):145-51. PubMed ID: 7690386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midodrine, a new therapeutic agent: recent experience.
    Puchmayer V; Herdovà J; Krejcová H; Masopust J
    Int Angiol; 1993 Jun; 12(2):113-8. PubMed ID: 7690381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics of midodrine, an antihypotensive agent.
    Zachariah PK; Bloedow DC; Moyer TP; Sheps SG; Schirger A; Fealey RD
    Clin Pharmacol Ther; 1986 May; 39(5):586-91. PubMed ID: 2421958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of blood pressure circadian rhythm to cardiovascular complaints and orthostatic test results in patients with orthostatic dysregulation. Effects of midodrine on blood pressure circadian rhythm.
    Nagasawa K; Kurihara H; Yamanaka H; Hatta S
    Int Angiol; 1993 Jun; 12(2):103-9. PubMed ID: 7690380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gutron treatment of patients suffering from essential orthostatic hypotony. Part Two--Autonomic system investigation.
    Petelez T; Sosnowski M; Axenti I
    Int Angiol; 1993 Jun; 12(2):138-44. PubMed ID: 7690385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midodrine treatment in the management of severe orthostatic hypotension after hemangioblastoma surgery.
    Jabary NS; Sarabia R; Sanchez T; Gordillo R
    Acta Neurochir (Wien); 2007 Mar; 149(3):303-5; discussion 305-6. PubMed ID: 17334671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.